Insider · CIK 0001441500
Stefan Loren
Files at CLRB (Cellectar Biosciences, Inc.). First filing -, latest -.
Stefan Loren files SEC Form 4 as director at CLRB (Cellectar Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stefan Loren has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | CLRB Cellectar Biosciences, Inc. | AGrant or award Stock option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Feb 18, 2025 |
Questions about Stefan Loren
Answered from the filings on this page, as of the latest one.
Is Stefan Loren buying or selling?
Stefan Loren has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stefan Loren's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stefan Loren has 0.
Where does Stefan Loren file Form 4?
Stefan Loren has filed Form 4 at CLRB (Cellectar Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.